Metformin may reduce oral cancer risk in patients with type 2 diabetes
about
Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysisMetformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells.Sitagliptin use and thyroid cancer risk in patients with type 2 diabetes.Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.Sitagliptin and heart failure hospitalization in patients with type 2 diabetesMetformin use and cervical cancer risk in female patients with type 2 diabetesRosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes.Metformin and lung cancer risk in patients with type 2 diabetes mellitus.Sitagliptin and oral cancer risk in type 2 diabetes patients.Metformin use and its effect on gastric cancer in patients with type 2 diabetes: A systematic review of observational studies.
P2860
Q26738743-8AECE294-D467-4CA9-9CA0-22889FD69709Q33914014-47C0EF38-68EF-493A-A9DE-6B5F2D7059F5Q37269476-81783E90-6FFD-42C7-A924-5C18484093E9Q37274957-3B16091E-7657-4868-957B-81B3A8D87230Q37641835-D5706DBB-0FDE-4F3B-847A-3C130E6B24AEQ37644891-59113FE2-B1BD-4621-8B15-79DF10B3CF64Q37709423-0E947578-9AA0-4096-A293-F39F65DE8A2AQ37745840-B46B6283-2811-420B-B50E-5A569D832A31Q37745926-42B1BB1F-E50F-4D13-868D-C20FFC125842Q41092838-6157A695-E03F-4646-A2C3-523DF7B93797Q47096984-4C2C64BF-52A3-4B4A-958B-6D57C4399C3DQ49183232-A9EAB839-59F7-4DAB-8442-41E69470F858
P2860
Metformin may reduce oral cancer risk in patients with type 2 diabetes
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Metformin may reduce oral cancer risk in patients with type 2 diabetes
@ast
Metformin may reduce oral cancer risk in patients with type 2 diabetes
@en
type
label
Metformin may reduce oral cancer risk in patients with type 2 diabetes
@ast
Metformin may reduce oral cancer risk in patients with type 2 diabetes
@en
prefLabel
Metformin may reduce oral cancer risk in patients with type 2 diabetes
@ast
Metformin may reduce oral cancer risk in patients with type 2 diabetes
@en
P2860
P356
P1433
P1476
Metformin may reduce oral cancer risk in patients with type 2 diabetes
@en
P2093
Chin-Hsiao Tseng
P2860
P304
P356
10.18632/ONCOTARGET.6626
P407
P577
2015-12-16T00:00:00Z